Navigation Links
Strides Made in Hemophilia Research
Date:6/16/2009

Successful blood-clotting in lab could pave way for human trials, researchers say

TUESDAY, June 16 (HealthDay News) -- Researchers studying the bleeding disease hemophilia in mice have increased the rodents' ability to produce a crucial blood-clotting protein, a new study says. Their success may pave the way for human trials.

Past studies have successfully introduced a gene into animals' cells to make the clotting protein, Factor VIII, which is missing in people with hemophilia. But attempts at gene therapy in humans have been disappointing, the study authors note.

In the new study, the researchers say they have developed an approach to target genes in mouse liver sinusoidal endothelial cells, which are the main source of Factor VIII.

Researchers hope the new approach will be a step toward successful human clinical trials in individuals with hemophilia A, the most common form of the inherited disorder.

The study by researchers from the University of Minnesota Medical School in Minneapolis is in the June issue of the Journal of Clinical Investigation.

In the study, researchers used nanoparticles coated with hyaluron to target liver sinusoidal endothelial cells. The nanoparticles contained a therapeutic gene (Factor VIII) as well as Sleeping Beauty, a genetic element that helps the therapeutic gene become inserted into the genome of the targeted cells.

Fifty weeks after the treatment, mice injected with these nanoparticles had Factor VIII levels that were the same as those of normal mice. Bleeding times were also similar to those of normal mice.

According to a news release from the journal, it is the authors hope that the combination of Sleeping Beauty and the cell-specific nanocapsule delivery system will result in a successful gene therapy.

More information

The National Heart, Lung and Blood Institute has more on hemophilia.



-- Jennifer Thomas



SOURCE: Journal of Clinical Investigation, news release, June 8, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Twenty-Five Individuals Honored by Yoplait(R) for Making Extraordinary Strides in the Fight Against Breast Cancer
2. GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend
3. Gentiva Safe Strides(R) Home Balance Therapy Program is Reducing Risk of Dangerous Falls and Relieving Pain for Thousands of Older Americans
4. Stroller Strides(R) Franchises Succeed Despite Economic Climate
5. Stroller Strides(R) Signs Pampers(R) as Premier Sponsor for 2009
6. Womans Day Presents the Sixth Annual Red Dress Awards Honoring Women Making Strides in the Fight Against Heart Disease
7. Cystic Fibrosis Foundation Launches GREAT STRIDES Walks Nationwide at 600 Locations
8. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
9. Transplanted Liver Lining Cells May Cure Hemophilia
10. Wyeths XYNTHA Approved by FDA for Treatment of Hemophilia A
11. eWorld Companies, Inc. Establishes Strategic Alliance With Hemophilia Foundation of Southern California
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Strides Made in Hemophilia Research
(Date:1/24/2017)... ... January 24, 2017 , ... Element Blue ™, a ... a strategic partnership with Lucidworks , the company transforming the way people ... platform for building powerful enterprise search applications. , Element Blue is a global ...
(Date:1/24/2017)... ... January 24, 2017 , ... Manzo Pharmaceuticals, LLC., announced ... Registered Trademark by the United States Patent and Trademark Office. The purpose ... confuse consumers into thinking that other products are similar to the patented Lacto-Freedom ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... the semi-final round of the 2017 Cupid's Cup Entrepreneurship Competition. Chaired by Under ... year in 2017. The entrepreneurs will showcase their businesses on February 6, 2017, ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... it has officially formed a distribution partnership with Byers Scientific & Manufacturing ... management industry. , Through the agreement, OMI Industries formulated a special version of ...
(Date:1/24/2017)... Rancho Santa Margarita, CA (PRWEB) , ... January 24, 2017 , ... ... career advancement platform for 21st century leadership, has named Hector M. Chavez, Manager, Employee ... cancer and diabetes treatment center - as its Hispanic Leader of the Month. City ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... Market Research Future has a half cooked research report on global ... Surgery & Integumentary System is growing rapidly and expected to reach ... Market Highlights ... Global Plastic Surgery & Integumentary System Market has been evaluated as ... high growth figures and thriving in the coming future. There has ...
(Date:1/24/2017)... -- Analysis of the Liquid Biopsy Market by Sample ... our new study reveals trends, R&D progress, and predicted revenues ... in this sector you must read this brand new report. ... assessing data, trends, opportunities and business prospects there. ... Discover How to Stay Ahead ...
(Date:1/24/2017)... SAN DIEGO , Jan. 24, 2017 /PRNewswire/ ... leader in clinical materials management services, is pleased ... Director of Operations. Kevin joins the Sherpa team ... to the highest level of service excellence. ... supply chain and pharmaceutical manufacturing industries. He has ...
Breaking Medicine Technology: